Success Story: Smooth Approval! An Assistant Professor From Sri Lanka Obtains NIW Success with Direct Premium Service

Client’s Testimonial:

“The quality of service and professionalism were exceptional. The team demonstrated meticulous attention to detail in preparing the petition letter, thoroughly reviewing it, and carefully assembling the entire package, showcasing a comprehensive understanding of the requirements and presenting my case effectively. Responses to questions were prompt and clear. Overall, I am very satisfied with the service and would highly recommend it to others.”

On January 23^rd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Professor in the Field of Robotics (Approval Notice).

General Field: Robotics

Position at the Time of Case Filing: Assistant Professor

Country of Origin: Sri Lanka

State of Residence at the Time of Filing: Illinois

Approval Notice Date: January 23^rd, 202

Processing Time: 2 months, 9 days (Premium Processing Requested)

Case Summary:

Innovations in assistive technology are transforming healthcare and rehabilitation worldwide. Our client, an accomplished robotics expert with a Ph.D. in computer and information sciences, has devoted a career to advancing the design of personalized wearable robotic devices that restore mobility, independence, and quality of life for amputees and individuals with disabilities. This work, integrating robotics, machine learning, and biomechanics, addresses a national priority by improving accessibility, reducing healthcare burdens, and enhancing inclusion for millions of Americans living with mobility impairments.

With the guidance of the North America Immigration Law Group (NAILG), the client’s I-140 National Interest Waiver (NIW) petition was approved through direct premium processing, a reflection of the strength of the case and the substantial impact of the client’s research. The approval underscores both the client’s recognized record of accomplishment and NAILG’s strategic presentation of evidence demonstrating national importance and professional distinction.

Holding a doctorate in computer and information sciences, the client has made notable contributions to soft robotics, bioinspired locomotion, and machine learning applications in rehabilitation devices. At the time of submission, the client had authored 4 peer-reviewed journal articles (2 first-authored) and 14 conference papers (8 first-authored) – a testament to the active and innovative role in advancing robotic design and control. With over 413 citations and 19 completed peer reviews for high-impact international journals and conferences, the client’s influence extends across both academic and applied research communities, confirming recognition as a thought leader in the field.

In preparing the petition, NAILG highlighted how the client’s research directly supports U.S. priorities in healthcare innovation, disability inclusion, and advanced manufacturing. By developing adaptive robotic systems that tailor assistance to each user’s needs, the client’s work provides scalable solutions to improve rehabilitation outcomes and support equitable access to healthcare technology.

Through this successful outcome, NAILG once again demonstrated its ability to present complex scientific accomplishments in a clear, compelling manner. The client’s continued work in wearable robotics will not only push the boundaries of human-centered engineering but also contribute directly to the United States’ mission of fostering technological innovation and improving the quality of life for people with disabilities.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.